Proven Record of Safety
Tissue Safety
RTI is committed to providing safe, high quality allografts for surgeons and their patients. We believe that the more you know about RTI Biologics, the more confident you will be in the safety of our tissue implants.
A statement from the CEO regarding tissue safety – 12/14/12
Summary of actions taken by RTI – 12/20/12
Update on FDA Warning Letter – 1/16/13
The safety of any tissue is contingent upon three stages – donor screening, laboratory testing and tissue preparation validated to address potential disease transmission.
For surgeries involving tissue implants, RTI has developed methodologies to address the risk of infection that could be caused by the implants themselves. Where possible, we use validated, proprietary sterilization processes – such as BioCleanse®, Tutoplast® and Cancelle™ SP – to provide safe tissue implants that have changed the lives of patients around the world.
We have provided more than five million implants with zero incidence of implant-associated infection. At RTI, that’s our track record, and we’re proud of it.